Table 1 Clinical parameters and overall survival- univariable analysis
Factor | N | 2-Year survival±s.e.m. | Median | Pa |
|---|---|---|---|---|
Gender | ||||
Male | 41 (65%) | 63%±8% | 44 | |
Female | 24 (35%) | 71%±10% | 66 | 0.41 |
Age at Diagnosis | ||||
Total <70 | (51–90 years) 31 | 77%±8% | 70 years N/A | |
>70 | 32 | 56%±9% | 34 | 0.004 |
Location | ||||
Head/neck | 20 (31%) | 48%±12% | 23 | |
Extremities | 29 (46%) | 76%+9% | 107 | |
Other | 15 (23%) | 70%+13% | 107 | 0.09 |
No. positive sentinel lymph nodes | ||||
1 | 47 | 71%±7% | 73 | |
2 | 11 | 63%±18% | 42 | |
>2 | 4 | 0% | 4 | <0.0001b |
Sentinel lymph node pattern | ||||
1 | 38 | 61%±9% | 35 | |
2 | 4 | 100% | N/A | |
3 | 11 | 73%+13% | N/A | |
4 | 1 | 100% | N/A | |
5 | 10 | 53%±20% | N/A | 0.28 |
1 | 38 | 61%±9% | 35 | |
2–5 | 26 | 73%+9% | N/A | 0.03 |
Extracapsular extension (pattern 1) | ||||
No | 10 | 70%±14% | 107 | |
Yes | 15 | 56%±14% | 26 | 0.27 |
Immunosuppressed | ||||
No | 47 | 78%±7% | 73 | |
Yes | 14 (23%) | 40%±14% | 19 | 0.12 |
